Lumibird SA (EPA:LBIRD)
21.40
+1.00 (4.90%)
Oct 20, 2025, 1:42 PM CET
Lumibird Revenue
Lumibird had revenue of 108.28 million EUR in the half year ending June 30, 2025, with 9.97% growth. This brings the company's revenue in the last twelve months to 219.1 million, up 5.67% year-over-year. In the year 2024, Lumibird had annual revenue of 210.06 million with 1.70% growth.
Revenue (ttm)
219.10M
Revenue Growth
+5.67%
P/S Ratio
2.05
Revenue / Employee
205.15K
Employees
1,027
Market Cap
449.24M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 210.06M | 3.50M | 1.70% |
Dec 31, 2023 | 206.55M | 12.26M | 6.31% |
Dec 31, 2022 | 194.29M | 27.91M | 16.77% |
Dec 31, 2021 | 166.39M | 36.88M | 28.48% |
Dec 31, 2020 | 129.51M | 16.85M | 14.96% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sanofi | 45.74B |
EssilorLuxottica Société anonyme | 27.24B |
Eurofins Scientific SE | 7.14B |
emeis Société anonyme | 5.77B |
Clariane SE | 5.31B |
bioMérieux | 4.12B |
Ipsen | 3.76B |
Sartorius Stedim Biotech | 2.95B |